Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions
NCT00835640
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Fexofenadine 180 mg tablets
DRUG:
ALLEGRA® 180 mg tablets
Sponsor
Teva Pharmaceuticals USA